Dr Reddy’s Laboratories Ltd share price target is in focus for long-term investors, and here the base price is taken as your provided ₹1,346.40. Dr Reddy’s Laboratories Ltd share price target looks important because the company operates across four main segments: generics, API and services, innovative medicines, and consumer health, giving it a diversified pharmaceutical base.
Dr Reddy’s Laboratories Ltd share price target also remains relevant because the company has a broad global footprint and scale. Dr. Reddy’s says it has more than 24,000 employees and presence in 66 countries, while its API business highlights decades of scientific depth and supply reach across major markets.
Dr Reddy’s Laboratories Ltd share price target 2026
Dr Reddy’s Laboratories Ltd share price target for 2026 is expected to move from ₹1,346.40 – ₹1,358.20 in April toward ₹1,508 – ₹1,528 by December. Dr Reddy’s Laboratories Ltd share price target in 2026 may stay supported by portfolio depth, regulated market exposure, and fresh product opportunities, including the company’s plan to launch a lower-priced generic obesity drug after semaglutide patent expiry in India.
| Month | Price Outlook (INR) |
|---|---|
| April | ₹1,346.40 – ₹1,358.20 |
| May | ₹1,368 – ₹1,382 |
| June | ₹1,360 – ₹1,374 |
| July | ₹1,392 – ₹1,408 |
| August | ₹1,426 – ₹1,444 |
| September | ₹1,416 – ₹1,432 |
| October | ₹1,452 – ₹1,470 |
| November | ₹1,482 – ₹1,502 |
| December | ₹1,508 – ₹1,528 |
ALSO READ: Trent Ltd share price target 2026, 2027, 2028, 2029, 2030, 2031—Future Forecast, Monthly Outlook
Dr Reddy’s Laboratories Ltd share price target 2027
Dr Reddy’s Laboratories Ltd share price target for 2027 could rise toward ₹1,654 – ₹1,682 by year-end. Dr Reddy’s Laboratories Ltd share price target in 2027 may improve if domestic demand, consumer health expansion, and specialty launches remain healthy.
| Month | Price Outlook (INR) |
|---|---|
| January | ₹1,508 – ₹1,528 |
| February | ₹1,532 – ₹1,554 |
| March | ₹1,522 – ₹1,542 |
| April | ₹1,556 – ₹1,580 |
| May | ₹1,586 – ₹1,612 |
| June | ₹1,574 – ₹1,598 |
| July | ₹1,608 – ₹1,634 |
| August | ₹1,628 – ₹1,656 |
| September | ₹1,616 – ₹1,642 |
| October | ₹1,638 – ₹1,666 |
| November | ₹1,646 – ₹1,674 |
| December | ₹1,654 – ₹1,682 |
Dr Reddy’s Laboratories Ltd share price target 2028
Dr Reddy’s Laboratories Ltd share price target for 2028 may reach ₹1,812 – ₹1,848 by December. Dr Reddy’s Laboratories Ltd share price target in 2028 can stay firm if API strength and regulated-market launches continue supporting revenue quality.
| Month | Price Outlook (INR) |
|---|---|
| January | ₹1,654 – ₹1,682 |
| February | ₹1,680 – ₹1,710 |
| March | ₹1,668 – ₹1,696 |
| April | ₹1,706 – ₹1,738 |
| May | ₹1,740 – ₹1,774 |
| June | ₹1,726 – ₹1,758 |
| July | ₹1,762 – ₹1,798 |
| August | ₹1,784 – ₹1,822 |
| September | ₹1,770 – ₹1,806 |
| October | ₹1,794 – ₹1,832 |
| November | ₹1,802 – ₹1,840 |
| December | ₹1,812 – ₹1,848 |
Dr Reddy’s Laboratories Ltd share price target 2029
Dr Reddy’s Laboratories Ltd share price target for 2029 is projected near ₹1,982 – ₹2,028 by December. Dr Reddy’s Laboratories Ltd share price target in 2029 may strengthen if margin profile improves and specialty products scale further.
| Month | Price Outlook (INR) |
|---|---|
| January | ₹1,812 – ₹1,848 |
| February | ₹1,840 – ₹1,878 |
| March | ₹1,826 – ₹1,862 |
| April | ₹1,866 – ₹1,908 |
| May | ₹1,904 – ₹1,948 |
| June | ₹1,888 – ₹1,930 |
| July | ₹1,928 – ₹1,972 |
| August | ₹1,952 – ₹1,998 |
| September | ₹1,936 – ₹1,980 |
| October | ₹1,962 – ₹2,008 |
| November | ₹1,970 – ₹2,018 |
| December | ₹1,982 – ₹2,028 |
ALSO READ: Trent Ltd share price target 2026, 2027, 2028, 2029, 2030, 2031—Future Forecast, Monthly Outlook
Dr Reddy’s Laboratories Ltd share price target 2030
Dr Reddy’s Laboratories Ltd share price target for 2030 could move toward ₹2,168 – ₹2,224 by year-end. Dr Reddy’s Laboratories Ltd share price target in 2030 may benefit from better operating leverage and diversified global healthcare demand.
| Month | Price Outlook (INR) |
|---|---|
| January | ₹1,982 – ₹2,028 |
| February | ₹2,012 – ₹2,060 |
| March | ₹1,996 – ₹2,042 |
| April | ₹2,040 – ₹2,092 |
| May | ₹2,082 – ₹2,136 |
| June | ₹2,064 – ₹2,116 |
| July | ₹2,108 – ₹2,164 |
| August | ₹2,134 – ₹2,192 |
| September | ₹2,116 – ₹2,172 |
| October | ₹2,146 – ₹2,204 |
| November | ₹2,156 – ₹2,214 |
| December | ₹2,168 – ₹2,224 |
ALSO READ: UPL Ltd share price target 2026, 2027, 2028, 2029, 2030, 2031—Future Forecast, Monthly Outlook
Dr Reddy’s Laboratories Ltd share price target 2031
Dr Reddy’s Laboratories Ltd share price target for 2031 may reach ₹2,372 – ₹2,442 by December. Dr Reddy’s Laboratories Ltd share price target in 2031 may reflect stronger re-rating if execution, launches, and profitability stay favorable.
| Month | Price Outlook (INR) |
|---|---|
| January | ₹2,168 – ₹2,224 |
| February | ₹2,202 – ₹2,262 |
| March | ₹2,184 – ₹2,242 |
| April | ₹2,232 – ₹2,296 |
| May | ₹2,278 – ₹2,344 |
| June | ₹2,258 – ₹2,322 |
| July | ₹2,306 – ₹2,374 |
| August | ₹2,336 – ₹2,406 |
| September | ₹2,316 – ₹2,384 |
| October | ₹2,350 – ₹2,420 |
| November | ₹2,360 – ₹2,430 |
| December | ₹2,372 – ₹2,442 |
conclusion
Dr Reddy’s Laboratories Ltd share price target shows a gradual long-term path from ₹1,346.40 to nearly ₹2,372 – ₹2,442 by 2031. Dr Reddy’s Laboratories Ltd share price target may appeal to investors who want exposure to a diversified pharma company with generics, API, consumer health, and innovation-led opportunities.
FAQs
What is the Dr Reddy’s Laboratories Ltd share price target for 2026?
Dr Reddy’s Laboratories Ltd share price target for 2026 is expected around ₹1,508 – ₹1,528 by December.
What is the Dr Reddy’s Laboratories Ltd share price target for 2027?
Dr Reddy’s Laboratories Ltd share price target for 2027 could move toward ₹1,654 – ₹1,682.
What is the Dr Reddy’s Laboratories Ltd share price target for 2029?
Dr Reddy’s Laboratories Ltd share price target for 2029 is projected near ₹1,982 – ₹2,028.
What is the Dr Reddy’s Laboratories Ltd share price target for 2031?
Dr Reddy’s Laboratories Ltd share price target for 2031 may reach ₹2,372 – ₹2,442 by year-end.
Is Dr Reddy’s Laboratories Ltd a good long-term stock?
Dr Reddy’s Laboratories Ltd share price target suggests long-term potential, but investors should track U.S. competition, product pricing, and launch execution carefully.
Disclaimer: This content is for educational and informational purposes only and should not be treated as investment advice.
A stock market enthusiast with hands-on experience in trading. He writes simple and practical content to help people understand the market better.